Open company graph database — free web & API
Login

Sato Pharmaceutical

佐藤製薬株式会社
Ticker
—
Listed market
—
Country
Japan
Employees (consolidated)
1,000
Related companies
5
§01

Basic information

BASIC
Head office
1-5-27 Motohigashi Akasaka, Minato-ku, Tokyo 107-0051
Chief executive
Seiichi Sato
Capital
2,000,000,000 JPY (20 100 millionJPY)
Employees (non-consolidated)
Employees (consolidated)
1,000 people
Start date
1939-08-01
End date
§02

Websites

1 DOMAINS
§03

Business

6
Pharmaceutical businessManufacturing and sale of veterinary medicinesResearch and developmentDistribution and salesPharmaceutical manufacturingPharmaceutical sales
§04

Related companies

5 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Medix Sato Corporation
Group
Sato Pharmaceutical
Group
キップ薬品株式会社
Group
佐藤製薬股份有限公司
Group
B & H Satou Co., Ltd.
Group
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

22 EVENTS

Sato Pharmaceutical was founded in Chidamaki-cho, Higashimontokyo (now Yayoicho 1-chome, Bunkyo-ku). On April 15, Taisho 4, the founder, Sato Koichi, hung the sign "Sato Pharmaceutical". At the time of founding, the company building was a single six-tatami room on the second floor of a Go club, equipped only with a large milk bowl, a pound bottle, and a chemical balance. The only reliable means of sales was a single bicycle, making the launch of the pharmaceutical shop modest. Nevertheless, with the determination to try on his own, the pharmaceutical business began with Koichi as the sole entrepreneur.Sources

The company was reorganized from Sato Pharmaceutical to Sato Pharmaceutical Co., Ltd., and the headquarters was moved to Oimachi (now the Shinagawa Research & Development Center). The site of the former factory in Oimachi, Shinagawa, was purchased and a new two‑story pharmaceutical plant was built. The 1,200‑tsubo (about 4,000 m²) plant impressed young employees. The new plant began operations on August 1, which was designated as the anniversary of the founding of Sato Pharmaceutical.Sources

The company was reorganized from Sato Pharmaceutical Co., Ltd. to Sato Pharmaceutical Co., Ltd. During this period, amid the expansion of the Sino‑Japanese conflict, labor shortages and shortages of pharmaceutical raw materials led to the establishment of the National Pharmaceutical Control Corporation, and the company was subject to control. Under these circumstances, Sato Pharmaceutical strengthened its response to the military, supplying the Japanese Pharmacopoeia preparations and creosote tablets under the name "Bō‑Rō‑Maru" to the army.Sources

The focus shifted to the production and sale of OTC pharmaceuticals (consumer drugs). In 1950, the Pharmaceutical Affairs Law was amended, removing controls and creating a competitive market. This led to intense price competition for prescription drugs. In May 1952, Sato Pharmaceutical formally decided to shift its focus to "consumer‑oriented drugs". That same year, the Sato Cooperation Association (later SMA) was founded.Sources

TV commercials began airing in 1959, the year of the Crown Prince’s marriage (now Emperor Emeritus). Television sales exploded to watch the broadcast. In this context, commercials featuring Stona and others had a greater promotional effect than expected. See the CM and video page.Sources

"Stona" was released. The CM song "Kaze no Season no Omoiyari. 1 in Suimin, 2 in Stona" also spread. Stona was well received immediately after launch and became a hit product. See the Stona site.Sources

The mascot character "Sato‑chan" was introduced. In 1959, to commemorate the Crown Prince’s marriage, the mascot "Sato‑chan" was announced. The first Sato‑chan was created by the famous fairy‑tale writer and scenario writer Iizawa Ko and the illustrator Togata Shigeomi. See Sato‑chan City.Sources

Yasuko Sawaguchi was cast as Stona’s image character. She was a popular pure‑type top star. She co‑starred with Santa Claus and Sato‑chan in an anime, promoting Stona’s effectiveness with a gentle expression.Sources

In September 2000, a donation course was established at Tokyo Pharmaceutical University, the alma mater of founder and chairman Sato Koichi. The course, aimed at training pharmacists for the self‑medication era, became the first Japanese course to systematize OTC pharmaceutical studies, attracting industry attention.Sources

The CG character appeared in the 2001 Asus CM "Crocodile Sermon". Set in an izakaya, the crocodile says "For gum disease, use Asus. First 60 g for a month!" targeting the typical salaryman. The Kansai dialect voice‑over was performed by Enri Hiroshi.Sources

From 2003, Ichiro became the face of Yunkel. With his success in Major League Baseball, the "Ichiro’s Winning Drink Yunkel" gained international attention as a nutritional supplement.Sources

In September 2003, the acne treatment drug "Darasin T Gel 1%" was launched. The product, a new formulation of clindamycin phosphate ester, had long been awaited by medical professionals. Two years after launch, "Darasin T Gel 1%" was adopted by over 80% of university hospitals in Japan, becoming a flagship product in the medical‑device division.Sources

The Kazuza Academia factory (a drink manufacturing plant) was completed and began full operation in November 2003. The plant features large mixing tanks, a high‑speed automated filling line, and automatic inspection with CCD cameras, incorporating advanced technology.Sources

In 2003, Tamori, also known as Mr. Yunker, returned as Mr. Ases. He delivers a unique CM character performance with the rapid tongue-twister "Hanamogera-go yoroshiku, 'Akahaguki Harehaguki Yasehaguki'".Sources

In July 2003, a new research building was completed within the Shinagawa Research and Development Center, the R&D hub of Sato Pharmaceutical. The first floor houses a genetics laboratory, and new drug efficacy and pharmacology evaluations incorporating molecular biology techniques are advancing the expansion of existing products, including Yunker, and the development of OTC medicines with new benefits. The four‑story, two‑sided glass‑clad structure features a state‑of‑the‑art workflow floor and a library equipped with an IT environment.Sources

Satoshi Hoshino debuted in the Stona CM in the fall of 2004. With a high affinity among housewives choosing cold remedies, his image of "family‑friendly," "trustworthy," and "reassuring" matched Stona, leading to his selection. His caring nature shines through even in a single recommendation of Stona.Sources

In 2005, the classic character "Gingival Man" co‑starred with Tamori. Narrated with "80% of adults suffer from periodontal disease," Gingival Man, holding a 60g laminate tube of Ases, delivered a persuasive line, "This is it!", marking a full revival.Sources

From 2005 to 2019, professional golfer Yokonome Sakura appeared in Salometeel CM. Her high‑profile image of "competence" and "approachable" matched the perceived effect of Salometeel, leading to her casting.Sources

Following the installation at the Kazusa plant in 2009, solar panels began operating at the Hachioji plant. By 2013, both plants expanded panels, achieving 1.25 times the power generation and reducing CO2.Sources

Starting in 2012, sarcopenia research began at Keio University. Looking toward future drug discovery, we actively engage in joint research with domestic and international companies, universities, and research institutions.Sources

Following the installation at the Kazusa plant in 2009, solar panels began operating at the Hachioji plant. By 2013, both plants expanded panels, achieving 1.25 times the power generation and reducing CO2.Sources

From 2018 to 2019, Yunker’s CM featured not only the image character Ichiro but also Mao Asada. The dream collaboration of two national stars became a reality.Sources

§07

News

0 ARTICLES

There is no news.

§08

Public records

GOV
National Tax Agency basic information2010401011411
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
佐藤製薬株式会社
Trade name (kana)
サトウセイヤク
Name in English
Sato Pharmaceutical Co., Ltd.
Corporation type
301
Address
〒107-0051 東京都港区元赤坂1丁目5番27号
Postal code
1070051
Prefecture code
13
City code
103
Address outside Japan
Prefecture in English
Tokyo
City in English
1-5-27, Moto-Akasaka, Minato-ku
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2023-08-14
Change date
2015-10-05
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
1
Trade name image ID
Address image ID
Sequence number
1445302
METI gBizINFO2010401011411
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
2010401011411
Trade name
佐藤製薬株式会社
Trade name (kana)
サトウセイヤク
Trade name (alphabet)
Sato Pharmaceutical Co., Ltd.
Registry closure date
Reason for registry closure
Registered address
東京都港区元赤坂1丁目5番27号
Postal code
1070051
Prefecture
東京都
Prefecture code
13
City or district
港区
City code
103
Street address
元赤坂1丁目5番27号
Organisation type
301
Processing type
01
Correction type
1
Status
Representative
代表取締役社長    佐  藤  誠  一
Capital
2000000000
Employees
967
Employees (male)
674
Employees (female)
293
Business summary
医薬品、医薬部外品、化粧品などの製造・販売
Website URL
Year founded
Business category
E:製造業
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2023-08-14
Key information
2010401011411
§09

Sources & updates

SOURCES
↑